Log in

CVE:PASPascal Biosciences Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: C$0.12
50-Day Range
MA: C$0.10
52-Week Range
Now: C$0.12
Volume65,122 shs
Average Volume77,212 shs
Market CapitalizationC$6.77 million
P/E RatioN/A
Dividend YieldN/A
Pascal Biosciences Inc., a drug discovery and development company, researches and develops biotechnology products for the treatment of cancer and for the enhancement of immune system in Canada. Its research programs include the development of Anti-VpreB, a therapeutic monoclonal antibody for treatment of B-cell precursor acute lymphoblastic leukemia in collaboration with the University of New Mexico; optimization of novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company has a collaboration agreement with the University of British Columbia. Pascal Biosciences Inc. is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A
Cash FlowC$0.01 per share
Book ValueC$0.00 per share



Market CapC$6.77 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PAS News and Ratings via Email

Sign-up to receive the latest news and ratings for PAS and its competitors with MarketBeat's FREE daily newsletter.

Pascal Biosciences (CVE:PAS) Frequently Asked Questions

How has Pascal Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Pascal Biosciences' stock was trading at C$0.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PAS stock has increased by 20.0% and is now trading at C$0.12. View which stocks have been most impacted by Coronavirus.

Has Pascal Biosciences been receiving favorable news coverage?

News stories about PAS stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pascal Biosciences earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutPascal Biosciences.

Who are some of Pascal Biosciences' key competitors?

What other stocks do shareholders of Pascal Biosciences own?

Who are Pascal Biosciences' key executives?

Pascal Biosciences' management team includes the following people:
  • Dr. Patrick W. Gray, CEO & Director (Age 67)
  • Ms. Judith F. Dalling L.L.B., CFO & Corp. Sec. (Age 64)
  • Mr. Carl Weissman, Acting Pres (Age 57)

What is Pascal Biosciences' stock symbol?

Pascal Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS."

How do I buy shares of Pascal Biosciences?

Shares of PAS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Pascal Biosciences' stock price today?

One share of PAS stock can currently be purchased for approximately C$0.12.

How big of a company is Pascal Biosciences?

Pascal Biosciences has a market capitalization of C$6.77 million. Pascal Biosciences employs 4 workers across the globe.

What is Pascal Biosciences' official website?

The official website for Pascal Biosciences is www.biommune.net.

How can I contact Pascal Biosciences?

Pascal Biosciences' mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The company can be reached via phone at +1-604-6886775.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.